The cobas ampliprep/cobas TaqMan HCV test, version 2.0, real-time pcr assay accurately quantifies hepatitis c virus genotype 4 RNA

Journal of Clinical Microbiology

Volumn 51, Issue 4, 2013, Pages 1078-1082

  Chevaliez, Stéphane ^a,b   Bouvier Alias, Magali ^a,b   Rodriguez, Christophe ^a,b   Soulier, Alexandre ^a,b   Poveda, Jean Dominique ^c   Pawlotskya, Jean Michel ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c LABORATOIRE CERBA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; TYROSINE; VIRUS RNA;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; BRANCHED DNA ASSAY; DNA DETERMINATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 4;

EID: 84875818749     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02004-12     Document Type: Article

References (20)

1. European Association for the Study of the Liver. 2011. EASL clinical practice guidelines: Management of hepatitis C virus infection. J. Hepatol 55:245-264.
2. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. 2011. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 54:1433-1444.
3. Chevaliez S, Rodriguez C, Pawlotsky JM. 2012. New virologic tools for management of chronic hepatitis B and C. Gastroenterology 142:1303-1313.
4. Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R. 2011. Boceprevir for previously treated chronic HCV genotype 1 infection. N. Engl. J. Med. 364:1207-1217.
5. Fried MW, Hadziyannis SJ, Shiffman ML, Messinger D, Zeuzem S. 2011. Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection. J. Hepatol. 55:69-75.
6. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S. 2011. Telaprevir for previously untreated chronic hepatitis C virus infection. N. Engl. J. Med. 364:2405-2416.
7. Poordad F, McCone J, Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP. 2011. Boceprevir for untreated chronic HCV genotype 1 infection. N. Engl. J. Med. 364: 1195-1206.
8. Jacobson IM, Bartels DJ, Gritz L, Kieffer TL, De Meyer S, Tomaka F, Bengtsson L, Luo D, Adiwijaya BS, Kauffman RS, Picchio G, Adda N. 2012. Futility rules in telaprevir combination treatment. J. Hepatol 56(Suppl 2):S24.
9. Jacobson IM, Marcellin P, Zeuzem S, Sulkowski MS, Esteban R, Poordad F, Bruno S, Burroughs MH, Pedicone LD, Boparai N, Deng W, Dinubile MJ, Gottesdiener KM, Brass CA, Albrecht JK, Bronowicki JP. 2012. Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin. Hepatology 56:567-575.
10. Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM. 2012. Antiviral strategies in hepatitis C virus infection. J. Hepatol 56(Suppl 1):S88-S100.
11. Akhavan S, Ronsin C, Laperche S, Thibault V. 2011. Genotype 4 hepatitis C virus: Beware of false-negative RNA detection. Hepatology 53: 1066-1067.
12. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. 2007. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 46:22-31.
13. Chevaliez S, Bouvier-Alias M, Castera L, Pawlotsky JM. 2009. The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples. Hepatology 49:1397-1398.
14. Chevaliez S, Fix J, Soulier A, Pawlotsky JM. 2009. Underestimation of hepatitis C virus genotype 4 RNA levels by the Cobas AmpliPrep/Cobas TaqMan assay. Hepatology 50:1681.
15. Germer JJ, Bommersbach CE, Schmidt DM, Bendel JL, Yao JD. 2009. Quantification of genotype 4 hepatitis C virus RNA by the COBAS AmpliPrep/COBAS TaqMan hepatitis C virus test. Hepatology 50:1679-1680.
16. Kamal SM, Nasser IA. 2008. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47:1371-1383.
17. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coude M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourliere M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, Thiefin G, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrere JJ, Lunel-Fabiani F. 2005. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: The GEMHEP GenoCII Study. J. Viral Hepat. 12:405-413.
18. Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourliere M, Renou C, Tran A, Melin P, Hezode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, Lonjon-Domanec I, Pawlotsky JM. 2006. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology 131:1040-1048.
19. Soler M, Pellerin M, Malnou CE, Dhumeaux D, Kean KM, Pawlotsky JM. 2002. Quasispecies heterogeneity and constraints on the evolution of the 5= noncoding region of hepatitis C virus (HCV): Relationship with HCV resistance to interferon-alpha therapy. Virology 298:160-173.
20. Vermehren J, Colucci G, Gohl P, Hamdi N, Abdelaziz AI, Karey U, Thamke D, Zitzer H, Zeuzem S, Sarrazin C. 2011. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity. J. Clin. Microbiol. 49:3309-3315.